_version_ 1785090416663592960
author Marouf, Amira
Chaubard, Sammara
Michot, Jean Marie
Rossignol, Julien
Golfier, Camille
Allangba, Olivier
Philippe, Laure
Tessoulin, Benoit
Chauchet, Adrien
Deau, Bénédicte
Oberic, Lucie
Vargaftig, Jacques
Moignet, Aline
Clavert, Aline
Duléry, Rémy
Brisou, Gabriel
Tardy, Stéphanie
Fataccioli, Virginie
Houot, Roch
Olivier Casasnovas, Rene
Thieblemont, Catherine
Ghesquieres, Herve
Carras, Sylvain
Le Gouill, Steven
Cartron, Guillaume
Marabelle, Aurélien
Tournilhac, Olivier
Laurent Damaj, Gandhi
Gaulard, Philippe
Leval, Laurence De
Lemonnier, Francois
Bachy, Emmanuel
Hermine, Olivier
Couronné, Lucile
Jaccard, Arnaud
author_facet Marouf, Amira
Chaubard, Sammara
Michot, Jean Marie
Rossignol, Julien
Golfier, Camille
Allangba, Olivier
Philippe, Laure
Tessoulin, Benoit
Chauchet, Adrien
Deau, Bénédicte
Oberic, Lucie
Vargaftig, Jacques
Moignet, Aline
Clavert, Aline
Duléry, Rémy
Brisou, Gabriel
Tardy, Stéphanie
Fataccioli, Virginie
Houot, Roch
Olivier Casasnovas, Rene
Thieblemont, Catherine
Ghesquieres, Herve
Carras, Sylvain
Le Gouill, Steven
Cartron, Guillaume
Marabelle, Aurélien
Tournilhac, Olivier
Laurent Damaj, Gandhi
Gaulard, Philippe
Leval, Laurence De
Lemonnier, Francois
Bachy, Emmanuel
Hermine, Olivier
Couronné, Lucile
Jaccard, Arnaud
author_sort Marouf, Amira
collection PubMed
description
format Online
Article
Text
id pubmed-10428228
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104282282023-08-17 S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA Marouf, Amira Chaubard, Sammara Michot, Jean Marie Rossignol, Julien Golfier, Camille Allangba, Olivier Philippe, Laure Tessoulin, Benoit Chauchet, Adrien Deau, Bénédicte Oberic, Lucie Vargaftig, Jacques Moignet, Aline Clavert, Aline Duléry, Rémy Brisou, Gabriel Tardy, Stéphanie Fataccioli, Virginie Houot, Roch Olivier Casasnovas, Rene Thieblemont, Catherine Ghesquieres, Herve Carras, Sylvain Le Gouill, Steven Cartron, Guillaume Marabelle, Aurélien Tournilhac, Olivier Laurent Damaj, Gandhi Gaulard, Philippe Leval, Laurence De Lemonnier, Francois Bachy, Emmanuel Hermine, Olivier Couronné, Lucile Jaccard, Arnaud Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428228/ http://dx.doi.org/10.1097/01.HS9.0000967816.41118.bf Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Marouf, Amira
Chaubard, Sammara
Michot, Jean Marie
Rossignol, Julien
Golfier, Camille
Allangba, Olivier
Philippe, Laure
Tessoulin, Benoit
Chauchet, Adrien
Deau, Bénédicte
Oberic, Lucie
Vargaftig, Jacques
Moignet, Aline
Clavert, Aline
Duléry, Rémy
Brisou, Gabriel
Tardy, Stéphanie
Fataccioli, Virginie
Houot, Roch
Olivier Casasnovas, Rene
Thieblemont, Catherine
Ghesquieres, Herve
Carras, Sylvain
Le Gouill, Steven
Cartron, Guillaume
Marabelle, Aurélien
Tournilhac, Olivier
Laurent Damaj, Gandhi
Gaulard, Philippe
Leval, Laurence De
Lemonnier, Francois
Bachy, Emmanuel
Hermine, Olivier
Couronné, Lucile
Jaccard, Arnaud
S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
title S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
title_full S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
title_fullStr S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
title_full_unstemmed S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
title_short S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
title_sort s226: efficacy of anti-pd1 therapy in relapsed or refractory extranodal nk/t cell lymphoma: a matched cohort analysis from the lysa
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428228/
http://dx.doi.org/10.1097/01.HS9.0000967816.41118.bf
work_keys_str_mv AT maroufamira s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT chaubardsammara s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT michotjeanmarie s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT rossignoljulien s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT golfiercamille s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT allangbaolivier s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT philippelaure s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT tessoulinbenoit s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT chauchetadrien s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT deaubenedicte s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT obericlucie s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT vargaftigjacques s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT moignetaline s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT clavertaline s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT duleryremy s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT brisougabriel s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT tardystephanie s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT fatacciolivirginie s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT houotroch s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT oliviercasasnovasrene s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT thieblemontcatherine s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT ghesquieresherve s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT carrassylvain s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT legouillsteven s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT cartronguillaume s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT marabelleaurelien s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT tournilhacolivier s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT laurentdamajgandhi s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT gaulardphilippe s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT levallaurencede s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT lemonnierfrancois s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT bachyemmanuel s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT hermineolivier s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT couronnelucile s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa
AT jaccardarnaud s226efficacyofantipd1therapyinrelapsedorrefractoryextranodalnktcelllymphomaamatchedcohortanalysisfromthelysa